Sam Altman appeared on the social media platform X on Saturday to talk about the “most amazing encounter” he had with Paul S. Conyngham that week.
Conyngham is a senior data scientist who, with the help of various AI-powered large-scale language models, developed a personalized vaccine to save dogs with cancer.
“The best encounter I had this week was with Paul, who used ChatGPT and other LLMs to create an mRNA vaccine protocol to save his dog Rosie. This is an amazing story,” Altman said.
Altman also posted an excerpt from Conyngham’s long article on “X,” in which the data scientist clarified that the creation of the vaccine was the result of “actual scientific design work” that translated genomic data into a vaccine formulation and built a therapeutic framework around it, not a single prompt for the LLM.
The best encounter I had this week was with Paul. He used ChatGPT and other LLMs to create an mRNA vaccine protocol to save his dog Rosie. That’s an amazing story.
“Thanks to chatbots, I can now act as an individual, plan, teach, etc. with the power of research institutions.… https://t.co/akgD2Wz7d0
— Sam Altman (@sama) March 27, 2026
He said this was the result of a collaboration with chatbots, which “are now able to act” with the authority of research institutions responsible for planning, education, troubleshooting and compliance.
“As soon as I heard that, I thought, ‘This should be a company,'” Altman said.
Also read: Two major CEOs say AI shaped their decision to quit
“Also, Paul is an extraordinary guy. This should be easy, but it hasn’t happened yet.”
In his post, Conyngham detailed the process of speaking with veterinarians and collaborating with a team at a cancer research institute. This was for DNA analysis and sequencing to develop a treatment that could control the cancer in their dog Rosie.
Data scientists have used a number of techniques, along with the use of AI, to significantly reduce the time and cost required for analysis and complex 3D modeling to study cancer in canines. Conyngham ran into an impasse after a patent application was filed for a protein needed to stop cancer cells from growing, and its use was legally prohibited.
So Conyngham decided to develop a personalized vaccine that would allow dogs’ immune systems to fight cancer on their own, an attempt that was successful.
Also read: Unbelievable! 84-year-old grandmother falls in love with AI-generated human
Essential business intelligence, continuous LIVE TV, sharp market insights, practical personal finance advice and the latest articles on NDTV’s profits.
